Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 66323-1-Ig - Provider product page
- Provider
- Proteintech Group
- Product name
- Glutamine Synthetase antibody
- Antibody type
- Monoclonal
- Description
- KD/KO validated Glutamine Synthetase antibody (Cat. #66323-1-Ig) is a mouse monoclonal antibody that shows reactivity with human, pig and has been validated for the following applications: IF, IHC, WB,ELISA.
- Reactivity
- Human, Porcine
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1D10G8
- Vial size
- 20ul, 150ul
Submitted references C9ORF72 Deficiency Results in Neurodegeneration in the Zebrafish Retina.
TRIM9 promotes Müller cell-derived retinal stem cells to differentiate into retinal ganglion cells by regulating Atoh7.
Unique activities of two overlapping PAX6 retinal enhancers.
A novel method for generating glutamatergic SH-SY5Y neuron-like cells utilizing B-27 supplement.
Therapeutic targeting of glutamate dehydrogenase 1 that links metabolic reprogramming and Snail-mediated epithelial-mesenchymal transition in drug-resistant lung cancer.
Selective vulnerability of tripartite synapses in amyotrophic lateral sclerosis.
OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
Jaroszynska N, Salzinger A, Tsarouchas TM, Becker CG, Becker T, Lyons DA, MacDonald RB, Keatinge M
The Journal of neuroscience : the official journal of the Society for Neuroscience 2024 Jun 19;44(25)
The Journal of neuroscience : the official journal of the Society for Neuroscience 2024 Jun 19;44(25)
TRIM9 promotes Müller cell-derived retinal stem cells to differentiate into retinal ganglion cells by regulating Atoh7.
Zeng Q, Zhou J, Hua X
In vitro cellular & developmental biology. Animal 2023 Sep;59(8):586-595
In vitro cellular & developmental biology. Animal 2023 Sep;59(8):586-595
Unique activities of two overlapping PAX6 retinal enhancers.
Uttley K, Papanastasiou AS, Lahne M, Brisbane JM, MacDonald RB, Bickmore WA, Bhatia S
Life science alliance 2023 Nov;6(11)
Life science alliance 2023 Nov;6(11)
A novel method for generating glutamatergic SH-SY5Y neuron-like cells utilizing B-27 supplement.
Martin ER, Gandawijaya J, Oguro-Ando A
Frontiers in pharmacology 2022;13:943627
Frontiers in pharmacology 2022;13:943627
Therapeutic targeting of glutamate dehydrogenase 1 that links metabolic reprogramming and Snail-mediated epithelial-mesenchymal transition in drug-resistant lung cancer.
Wang Q, Wu M, Li H, Rao X, Ao L, Wang H, Yao L, Wang X, Hong X, Wang J, Aa J, Sun M, Wang G, Liu J, Zhou F
Pharmacological research 2022 Nov;185:106490
Pharmacological research 2022 Nov;185:106490
Selective vulnerability of tripartite synapses in amyotrophic lateral sclerosis.
Broadhead MJ, Bonthron C, Waddington J, Smith WV, Lopez MF, Burley S, Valli J, Zhu F, Komiyama NH, Smith C, Grant SGN, Miles GB
Acta neuropathologica 2022 Apr;143(4):471-486
Acta neuropathologica 2022 Apr;143(4):471-486
OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
Dai W, Xu L, Yu X, Zhang G, Guo H, Liu H, Song G, Weng S, Dong L, Zhu J, Liu T, Guo C, Shen X
Journal of hepatology 2020 May;72(5):909-923
Journal of hepatology 2020 May;72(5):909-923
No comments: Submit comment
No validations: Submit validation data